XML 86 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
Royalty Financing Agreement - Narrative (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Oct. 31, 2022
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 01, 2025
Debt Instrument [Line Items]          
Proceeds from issuance Royalty Financing Agreement   $ 0 $ 150,000 $ 0  
Accrued royalty and milestones payable   5,674 4,710    
Royalty Agreements          
Debt Instrument [Line Items]          
Royalty maximum 1.8        
Accrued royalty and milestones payable   $ 3,300 $ 2,100    
Maximum | Royalty Agreements          
Debt Instrument [Line Items]          
Royalty maximum 1.9        
ARIKAYCE Global Net Sales | Royalty Agreements          
Debt Instrument [Line Items]          
Royalty percentage 400.00%        
ARIKAYCE Global Net Sales | Subsequent Event | Royalty Agreements          
Debt Instrument [Line Items]          
Royalty percentage         450.00%
Brensocatib Global Net Sales | Subsequent Event | Royalty Agreements          
Debt Instrument [Line Items]          
Royalty percentage         75.00%
Secured Debt | Royalty Agreements          
Debt Instrument [Line Items]          
Proceeds from issuance Royalty Financing Agreement $ 150,000        
Revenue interest payment 150,000        
Original Term Loan balance 150,000        
Lenders fees and deal expenses 3,600        
Proceeds from royalty financing agreement, net $ 146,400        
Effective interest rate 12.40%